Galectin Therapeutics reported $173.9M in Market Capitalization this November of 2026, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
AbbVie USD 508.97B 46.71B Nov/2026
Bristol-Myers Squibb USD 127.46B 9.81B Sep/2026
Gilead Sciences USD 184.82B 27.96B Sep/2026
Immunic USD 64M 23M Dec/2025
Incyte USD 24.6B 1.95B Sep/2026
Merck USD 375.59B 17.09B Nov/2026